Bio-Rad Labs (BIO) Misses Q1 EPS by 46c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 --0%
Revenue Growth %: -4.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -4.3%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $3.34, $0.46 worse than the analyst estimate of $3.80. Revenue for the quarter came in at $677 million versus the consensus estimate of $696.08 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
